(Q34564119)

3 August 2017

Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers (English)

1 reference

3 August 2017

0 references

2

Carl L Hart

1 reference

3 August 2017

1

Margaret Haney

1 reference

3 August 2017

3

Richard W Foltin

1 reference

PubMed ID

16407903

3 August 2017

language of work or name

English

0 references

publication date

11 January 2006

1 reference

3 August 2017

Neuropsychopharmacology

1 reference

3 August 2017

31

1 reference

3 August 2017

8

1 reference

3 August 2017

1814-1821

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300999

3 August 2017

0 references

cites work

A potential role for GABA(B) agonists in the treatment of psychostimulant addiction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

The GABA(B) antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

The effect of stimulant and sedative use on treatment outcome of patients admitted to methadone maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Demonstration of naturalistic methods for cocaine smoking by human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Risperidone for the treatment of cocaine dependence: randomized, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Effects of pergolide on intravenous cocaine self-administration in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Comparative treatment effectiveness. Effects of program modality and client drug dependence history on drug use reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

A pilot trial of topiramate for the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

The neurobiology of drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Disulfiram effects on acute cocaine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Failure of baclofen to modulate discriminative-stimulus effects of cocaine or methamphetamine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Effects of GABA agonists and GABA-A receptor modulators on cocaine discrimination in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Imipramine treatment of cocaine abuse: possible boundaries of efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Baclofen attenuates the reinforcing effects of cocaine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Enhanced treatment outcomes for cocaine-using methadone patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

Effects of GABAergic modulators on food and cocaine self-administration in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

7 January 2021

Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

7 January 2021

Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

7 January 2021

The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300999

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300999

1 reference

PubMed ID

16407903

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

16407903